Michael F MacLean Insider Trading
Get free email notifications about insider trading for Michael F MacLean.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael F MacLean. Michael F MacLean is a SVP, Chief Accounting Officer in BIOGEN INC. ($IDPH) and a Chief Financial Officer in Avidity Biosciences, Inc. ($RNA) and a Chief Financial Officer in AKCEA THERAPEUTICS, INC. ($AKCA).
Address: 14 CAMBRIDGE CENTER CAMBRIDGE 02142 MA
Companies in which Michael F MacLean is an Insider
AKCEA THERAPEUTICS, INC.
Trading Symbol: AKCAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael F MacLean: Chief Financial Officer
Holdings: 48,000 shares
Latest Transaction: Jan 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Avidity Biosciences, Inc.
Trading Symbol: RNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael F MacLean: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOGEN INC.
Trading Symbol: IDPHIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Michael F MacLean: SVP, Chief Accounting Officer
Holdings: 20,314 shares
Latest Transaction: Mar 23 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael F MacLean
Sentiment: All, AKCA, RNA, IDPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 04 2021 | RNA | Avidity Bioscience ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 22.34 | 92,000 | 2,055,280 | 92,000 | |
Jan 16 2020 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Grant | A | 0.00 | 28,000 | 0 | 48,000 | 20 K to 48 K (+140.00 %) |
Jan 03 2020 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 16.99 | 57,000 | 968,430 | 57,000 | |
Sep 23 2019 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jan 04 2019 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 30.73 | 83,000 | 2,550,590 | 83,000 | |
Jan 04 2018 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 17.38 | 30,000 | 521,400 | 30,000 | |
Sep 05 2017 | AKCA | AKCEA THERAPEUTICS ... | MacLean Michael F | Chief Financial Off ... | Option Exercise | A | 18.65 | 332,708 | 6,205,004 | 332,708 |